2025 annual financial data
Keros Therapeutics 2025 Operating margin
Direct answer
Operating margin was 28.94%.
Operating income was 70,623,000 USD and net income was 87,014,000 USD.
Operating cash flow was 107,505,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 244,061,000 USD
- Operating income
- 70,623,000 USD
- Net income
- 87,014,000 USD
- Operating cash flow
- 107,505,000 USD